Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE4
Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine
- Status
- COMPLETED
- Phase
- PHASE2
Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)
- Status
- COMPLETED
- Phase
- PHASE2
Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation
- Status
- RECRUITING
- Phase
- N/A
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Mobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE4
First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab
- Status
- UNKNOWN
- Phase
- NA
A Study to Assess the Safety of Myozyme® and of Aldurazyme® in Male and Female Participants of Any Age Group With Pompe Disease or With Mucopolysaccharidosis Type I (MPS I) in a Home-care Setting
- Status
- COMPLETED
- Phase
- N/A
Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)
- Status
- COMPLETED
- Phase
- N/A
Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy
- Status
- RECRUITING
- Phase
- PHASE2
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204)
- Status
- TERMINATED
- Phase
- PHASE2
Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
- Status
- COMPLETED
- Phase
- PHASE2
Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab
- Status
- RECRUITING
- Phase
- NA
Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52)
- Status
- COMPLETED
- Phase
- PHASE4
Pharmacokinetic Assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and Efanesoctocog Alfa (BIVV001) in Severe Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2